Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Clinical Development Services In Europe
54 services found
Manufactured by:AB2 Bio Ltd. based inLausanne, SWITZERLAND
AB2 Bio has developed the first and proprietary assay to detect and measure free IL-18 in body fluids, which gives us the capability of identifying diseases associated with free IL-18 levels. The assay could also be used as a companion diagnostic to select patients most likely to respond to treatment with ...
by:Novadiscovery based inLyon, FRANCE
Explore various regimens (dose, number of administrations per day, time between administrations, duration of treatment). Identify subgroups of optimal responders / theranostic biomarkers. Leverage real-world data to inform clinical trial ...
by:Oncodesign based inDijon, FRANCE
Complementary expertise for successful progress at each stage of your development. After the discovery and proof-of-concept phases, the preclinical development of new therapeutic entities is a critical step for the regulatory approval of the first-in-man administration and the transition to the early phases of clinical trials. D-VLOP, a network ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Pluristem’s goal is to provide patients, physicians and healthcare systems around the globe with standardized, easy to use and highly effective PLX cell products that need no genetic or tissue matching prior to administration. We are active with many respectful regulatory agencies worldwide to advance our clinical programs towards marketing. Part of our ...
by:International Drug Development Institute (IDDI) based inLouvain-la-Neuve, BELGIUM
Aiming at optimizing your clinical development strategy, our expert consultants develop the innovative strategies and capabilities needed to launch products with the greatest potential for commercial success and improved patient outcomes. ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Femoral neck fracture is the most common form of hip fracture with annual treatment costs in the U.S. estimated to be between $10 to $15 billion, and are expected to rise due to the aging population, with mortality rates of up to 36%. *click for further information about Muscle injury due to total hip ...
Manufactured by:Destiny Pharma plc based inBrighton, UNITED KINGDOM
The company is focused on the clinical development and commercial exploitation through partnering of its highly innovative anti-infective portfolio and has an open door policy to discussing potential business relationships. These range from partnering and licensing through to investment and non-dilutive funding as well as risk sharing and joint ventures with ...
by:Neuron Experts based inMarseille, FRANCE
A customized activity aimed to disclose a potential neuroprotective and/or neurotrophic activity of new molecules, as the absence of neurotoxicity, using programs specifically elaborated and tailored according to our customers’ needs. Neuron Experts provides cultures specifically developed to reproduce human pathologies and to predict the activity of a molecule in a ...
Distributed by:Avicanna Inc. based inToronto, ONTARIO (CANADA)
Advanced scientific platform for drug delivery, pre-clinical and clinical development. Team of 10+ scientists, deploying optimized proprietary methodologies in extraction, formulation development, analytical testing, pre-clinical models, and clinical development. Comprehensive IP ...
by:Genmab A/S based inCopenhagen V, DENMARK
Using our antibody expertise to transform how cancer is treated; As a leader in the discovery and development of antibody therapeutics, we are inspired by nature, passionate about innovation and driven by data. Our commitment to patients pushes us to use our antibody biology expertise to pursue and produce differentiated, next-generation cancer treatments. Our research and ...
Manufactured by:Atriva Therapeutics GmbH based inTübingen, GERMANY
The company’s lead drug candidate is the MEK inhibitor zapnometinib. The small molecule, which can be administered orally (tablet), is under advanced clinical development in two severe respiratory viral diseases: COVID-19 and influenza, two disease areas with urgent need for effective ...
Manufactured by:Sartorius AG based inGoettingen, GERMANY
A more seamless transition into the clinic. Complex biopharmaceuticals and advanced therapies can present challenges during preclinical development. When implementing an albumin-based solution, Albumedix can help avoid unnecessary complications in your preclinical testing by creating species-specific recombinant albumins to suit your preclinical models. ...
by:Revvity Gene Delivery (formerly SIRION Biotech) based inHamburg, GERMANY
In the discovery of oncology therapeutics, Antibody-drug conjugates (ADCs) are rapidly gaining momentum, with hundreds of candidates advancing through clinical development. Whether your priority lies in assessing the epitope binding of your construct, evaluating the cytotoxic potency of the payload, or scrutinizing the efficacy of the linker in cleaving, each ...
Manufactured by:Bracco Spa based inMilan, ITALY
For years the Bracco Group has been investing substantial resources in research, pre-clinical and clinical development of Imaging Agents for in vivo imaging. IA are used with special equipment to provide physicians with detailed information for diagnoses and to monitor minimally invasive operating procedures. Technological advances in equipment, ...
Manufactured by:Novartis International AG based inBasel, SWITZERLAND
We are an innovative medicines company with research and development at our core. Our R&D engine powers an industry-leading pipeline focused on delivering transformative medicines to fight disease, restore possibility and help people live life on their own terms. Researchers in Biomedical Research work across several diseases areas to uncover insights into the origins and ...
by:Selvita S.A. based inKrakow, POLAND
These studies should be comparative in nature and should be designed to have appropriate sensitivity to detect relevant differences in the response to the similar biological medicinal product and the reference medicinal product. The scope of assays is in line with EMA guidelines (Guideline on non-clinical and clinical development of similar ...
by:PharmaLex GMBH based inFriedrichsdorf, GERMANY
The Global Statistics and Data Science (GSDS) team at PharmaLex delivers analytical support for the development of medical products–from early research through pre-clinical to late phase studies, plus manufacturing and health economics. We support our clients every step of the way–from discovery and non-clinical requirements to early ...
by:IBA based inLouvain-La-Neuve, BELGIUM
IBA takes a hands-on approach during the ramp up phase and uses our past experiences with our numerous clinical centers to develop a dedicated support program for the ramp up phase. This includes: patient recruitment help, national marketing package, additional education of referrers, collaboration with existing IBA centers for QA validation, and quality system ...
by:Akukon Ltd. based inHELSINKI, FINLAND
Akukon Audiovisual offers clinical research and development services like feasibility studies, technology and resource analysis, long-term investment plans and user ...
by:Eurofins bioskin ( formely Bioskin GmbH) based inHamburg, GERMANY
The regulatory pathway for dermatological products, in particular topically applied products, differs from those for other therapeutic indications and dosage forms. Various options of proof-of-concept designs will help you move your development programs into the best direction. Early development of proper strategies shortens timelines and reduces costs. ...